Answers are grounded in this paper and cite their sources.
Review explores advancements in liquid embolic agents for treating various peripheral diseases, highlighting implications in interventional oncology.
Various devices have been utilized for embolization, ranging from metallic coils and vascular plugs that serve as a nidus for thrombosis, to particles such as microbeads, temporary embolics like Gelfoam, and liquid embolics. Historically implemented for treatment of various neurovascular pathologies, liquid embolics can be customized to occlude at various size vessels ranging from capillaries for ischemia to arteries for bleeding. The ability to manipulate these properties has resulted in a recent growth in popularity among body interventional radiologists with multiple new agents undergoing development for implementation in a wide range of peripheral diseases. In this review, we discuss recent developments in the realm of liquid embolic materials and explore their new implications with a focus on use in interventional oncology.
No takes yet. Share an insight, caveat, or question.
Pecknold et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: